Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Nuvalent Discovered Novel NVL-520 for the Treatment of Non-Small Cell Lung Cancer
Nuvalent has developed NVL-520, a new treatment for patients with ROS1-positive metastatic non-small cell lung cancer who have previously undergone treatment with two or more ROS1 tyrosine kinase inhibitors...
Biogen Developed SKYCLARYS® (omaveloxolone), the First Therapy to treat Friedreich’s Ataxia
Biogen has developed SKYCLARYS®, marking a significant breakthrough as the inaugural therapeutic option for addressing Friedreich’s ataxia in adults and adolescents aged 16 years and older....
Chugai Pharmaceutical Develops Novel Crovalimab Antibody for the Treatment of Paroxysmal Nocturnal Haemoglobinuria
Chugai Pharmaceutical has developed a groundbreaking treatment named crovalimab, a humanised monoclonal antibody targeting complement C5, designed particularly for adults and adolescents...
Takeda Discovered First-of-its-kind Oral Treatment for Eosinophilic Oesophagitis
Takeda has discovered first-of-its-kind EOHILIA , the only FDA-approved oral therapy tailored for individuals aged 11 and above grappling with eosinophilic oesophagitis...
Regeneron Pharmaceuticals Introduced Dupixent® First and Only Treatment for Children with Eosinophilic Oesophagitis (EoE)
Regeneron Pharmaceuticals has introduced Dupixent® for treating paediatric patients aged 1 to 11 years with eosinophilic oesophagitis, weighing at least 15 kg. Dupixent, a fully human monoclonal antibody...
Alector Launched Breakthrough Latozinemab Antibody for Progranulin Gene Mutation (FTD-GRN)
Alector has introduced atozinemab, a groundbreaking investigational human monoclonal antibody crafted to obstruct sortilin, thereby boosting progranulin levels, offering promise in treating frontotemporal dementia with a progranulin gene mutation...
RadioMedix and Orano Moed Discovered Novel AlphaMedixTM for Gastroenteropancreatic Neuroendocrine Tumours
RadioMedix and Orano Moed have jointly developed a groundbreaking treatment named AlphaMedix™ for adults with unresectable or metastatic gastroenteropancreatic neuroendocrine tumours...
Ipsen Developed First-of-its-kind for Metastatic Pancreatic Adenocarcinoma
Ipsen has developed a groundbreaking treatment called Onivyde® in combination with oxaliplatin, fluorouracil, and leucovorin for adults with metastatic pancreatic adenocarcinoma as a first-line therapy....
Indiana University Unveils First-of-its-kind Gene Therapy for Amyotrophic Lateral Sclerosis
Indiana University has unveiled first-of-its-kind Qalsody, gene-based therapy for a rare form of amyotrophic lateral sclerosis caused by mutations in the superoxide dismutase 1...
Imperial College London Introduced World’s First TriNetra-Glio Blood Test for Brain Tumour
Imperial College London researchers have introduced the world's first simple blood test that could aid in diagnosing patients with the deadliest form of brain cancer, potentially sparing them from undergoing invasive...
